Epidemiology and Management of Liver Metastases From Colorectal Cancer
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
Abstract
Data were obtained from the population-based cancer registry of Burgundy (France).
The proportion of patients with synchronous liver metastases was 14.5%. Age-standardized incidence rates were 7.6 per 100,000 in males, 3.7 per 100,000 in females. The 5-year cumulative metachronous liver metastasis rate was 14.5%. It was 3.7% for TNM stage I tumors, 13.3% for stage II, and 30.4% for stage III (P
Citation impact
- FWCI
- 8.31
- Percentile
- 100%
- References
- 20
Authors
6- SMSylvain ManfrédiCorresponding
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
- CLCôme Lepage
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
- CHCyril Hatem
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
- OCOlivier Coatmeur
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
- JFJean Faivre
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
Topics & keywords
- Medicine
- Colorectal cancer
- Epidemiology
- Incidence (geometry)
- Metastasis
- Internal medicine
- Population
- Cancer registry
- Good health and well-being